Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a minor update to the page version.
    Difference
    0.0%
    Check dated 2026-05-18T03:42:13.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page footer was updated to reflect a newer ClinicalTrials.gov site revision (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:38:27.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T13:57:58.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added the term Gaucher disease type I as a keyword on the page to reflect the specific condition studied.
    Difference
    0.1%
    Check dated 2026-03-29T03:40:26.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed. This reflects a site versioning update and does not modify the study details or user interactions.
    Difference
    0.0%
    Check dated 2026-03-21T19:19:32.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T07:59:23.000Z thumbnail image

Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.